Krystexxa 8MG

Ended Awarded

Contract number
36C24525N0427
Awardee
Awarding agency
Obligated
$76,897

Award facts

Contract value 100% obligated
$76,896.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
La Vergne, TN 37086, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded to Horizon Therapeutics USA, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is for the supply of KRYSTEXXA (pegloticase), a medication used to treat chronic gout. The delivery order has a ceiling value of $76,896.72 and a completion date of March 4, 2025.

Horizon Therapeutics USA, Inc. is the prime contractor for this award, and there are no specific set-aside designations indicated. The contract is part of a larger $31,375,000 Blanket Purchase Agreement (BPA) held by Horizon with the VA's National Acquisition Center, covering the procurement of several specialty medications to support the VA's healthcare services for veterans. This BPA is established against the GSA Schedule for Pharmaceuticals and Drugs and allows VA medical centers and Veterans Integrated Service Networks (VISNs) to efficiently place orders for Horizon's portfolio of treatments.

Quick answers

Who was awarded contract 36C24525N0427?

36C24525N0427 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 28, 2025.

How much is contract 36C24525N0427 worth?

The government has obligated $76,897 on 36C24525N0427.

Is contract 36C24525N0427 an order under another contract?

Yes. 36C24525N0427 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0427 competed?

The extent of competition for 36C24525N0427 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award